US Patent Issued to REGENERON PHARMACEUTICALS on Feb. 13 for "Methods of treating allergy using anti-Bet v 1 antibodies" (New York, New Jersey, Connecticut Inventors)

  • Meagan P. O'Brien

Press/Media

Period14 Feb 2024

Media coverage

1

Media coverage

  • TitleUS Patent Issued to REGENERON PHARMACEUTICALS on Feb. 13 for "Methods of treating allergy using anti-Bet v 1 antibodies" (New York, New Jersey, Connecticut Inventors)
    Media name/outletUS Fed News
    Country/TerritoryUnited States
    Date14/02/24
    PersonsMeagan P. O'Brien
View all 1
View less